Position
Renaissance Technologies in Boundless Bio, Inc.
Back to the book · All holders of BOLD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $558.6K$1.10 → $2.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 341.4K | $409.7K | — | — | — | 0.0% |
| Q1 2026 | 399K | $438.9K | $1.10 | −$34.1K | $63.4K | 0.0% |
| Q2 2026 | 471.6K | $1.18M | $2.50 | $558.6K | $181.4K | 0.0% |